Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 12, 2010, Pages 2452-2457

  Desrumaux, Catherine ^a,b,e   Deckert, Valérie ^a,b   Lemaire Ewing, Stéphanie ^a,b,c   Mossiat, Claude ^a,d   Athias, Anne ^a,b   Vandroux, David ^b,c   Dumont, Laure ^b,c   Monier, Serge ^a,b   Pais De Barros, Jean Paul ^a,b   Klein, Alexis ^a,b   De Maistre, Emmanuel ^b,c   Blache, Denis ^a,b   Beley, Alain ^b,d   Marie, Christine ^b,d   Garnier, Philippe ^b,d   Lagrost, Laurent ^a,b,c  

^a Institut Médical de Génétique et d Immunologie   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c HÔPITAL DU BOCAGE   (France)

^d INSERM   (France)

^e University of Montpellier   (France)

Author keywords

blood coagulation; endothelial function; lipids; thrombosis; vascular biology

Indexed keywords

ALPHA TOCOPHEROL; PHOSPHOLIPID TRANSFER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; BRAIN BLOOD VESSEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; HYPERLIPIDEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOSIS; VASCULAR BIOLOGY;

EID: 78650358110     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.207654     Document Type: Article

References (40)

1. Tzotzas T, Desrumaux C, Lagrost L. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes Rev. 2009;10:403-411. Review.
2. Jarvik GP, Rajagopalan R, Rosenthal EA, Wolfbauer G, McKinstry L, Vaze A, Brunzell J, Motulsky AG, Nickerson DA, Heagerty PJ, Wijsman EM, Albers JJ. Genetic and non-genetic sources of variation in phospholipid transfer protein (PLTP) activity. J Lipid Res. 2010;51:983-990.
3. Luo Y, Shelly L, Sand T, Reidich B, Chang G, Macdougall M, Peakman MC, Jiang XC. Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes. J Pharmacol Exp Ther. 2010;332:1100-1106.
4. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, Tall AR. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med. 2001;7:847-852. Erratum in: Nat Med. 2001;7:973.
5. Jiang XC, Tall AR, Qin S, Lin M, Schneider M, Lalanne F, Deckert V, Desrumaux C, Athias A, Witztum JL, Lagrost L. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem. 2002;277:31850-31856.
6. Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, Jiang XC. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler Thromb Vasc Biol. 2003;23:1601-1607.
7. Oslakovic C, Krisinger MJ, Andersson A, Jauhiainen M, Ehnholm C, Dahlback B. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins. J Biol Chem. 2009;284: 5896-5904.
8. Desrumaux C, Deckert V, Athias A, Masson D, Lizard G, Palleau V, Gambert P, Lagrost L. Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering a-tocopherol to endothelial cells. FASEB J. 1999;13:883-892.
9. Klein A, Deckert V, Schneider M, Dutrillaux F, Hammann A, Athias A, Le Guern N, Pais de Barros JP, Desrumaux C, Masson D, Jiang XC, Lagrost L. a-Tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26:2160-2167.
10. Demougeot C, Bertrand N, Prigent-Tessier A, Garnier P, Mossiat C, Giroud M, Marie C, Beley A. Reversible loss of N-acetyl-aspartate in rats subjected to long-term focal cerebral ischemia. J Cereb Blood Flow Metab. 2003;23:482-489.
11. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol. 1985;17:497-504.
12. Desrumaux C, Risold PY, Schroeder H, Deckert V, Masson D, Athias A, Laplanche H, Le Guern N, Blache D, Jiang XC, Tall AR, Desor D, Lagrost L. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J. 2005;19:296-297.
13. Manor D, Morley S. The a-tocopherol transfer protein. Vitam Horm. 2007;76:45-65. Review.
14. Christopher MK. Structure and function of a-tocopherol transfer protein: implications for vitamin E metabolism and AVED. Vitam Horm. 2007; 76:23-43. Review.
15. Chow CK. Distribution of tocopherols in human plasma and red blood cells. Am J Clin Nutr. 1975;28:756-760.
16. Keaney JF Jr, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of a-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 1996;98:386-394.
17. Van Reempts J, Borgers M. Histopathological characterization of photochemical damage in nervous tissue. Histol Histopathol. 1994;9:185-195. Review.
18. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest. 1999;103:907-914.
19. Guyard-Dangremont V, Desrumaux C, Gambert P, Lallemant C, Lagrost L. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species: relation to atherogenesis susceptibility. Comp Biochem Physiol B Biochem Mol Biol. 1998;120:517-525.
20. Miki M, Tamai H, Mino M, Yamamoto Y, Niki E. Freeradical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by a-tocopherol. Arch Biochem Biophys. 1987;258:373-380.
21. Pekiner B, Pennock JF. Oxidation of human red blood cells by a free radical initiator and effects of radical scavengers. Biochem Mol Biol Int. 1994;33:1159-1167.
22. Simon E, Paul JL, Soni T, Simon A, Moatti N. Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem. 1997;43:285-289.
23. Siggins S, Bykov I, Hermansson M, Somerharju P, Lindros K, Miettinen TA, Jauhiainen M, Olkkonen VM, Ehnholm C. Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein. Atherosclerosis. 2007;190:114-123.
24. Brigelius-Flohe R. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med. 2009;46:543-554. Review.
25. Stocker R. Vitamin E. Novartis Found Symp. 2007;282:77-87; discussion 87-92, 212-218. Review.
26. Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J Ther 2010;17:e56-e65.
27. Kirmizis D, Chatzidimitriou D. Antiatherogenic effects of vitamin E: the search for the Holy Grail. Vasc Health Risk Manag. 2009;5:767-774. Review.
28. Kritharides L, Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis. 2002;164:211-219. Review.
29. Lehmann J. Comparative sensitivities of tocopherol levels of platelets, red blood cells and plasma for estimating vitamin E nutritional status in the rat. Am J Clin Nutr. 1981;34:2104-2110.
30. Lehmann J, Rao DD, Canary JJ, Judd JT. Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes, and red blood cells. Am J Clin Nutr. 1988;47:470-474.
31. Bonithon-Kopp C, Coudray C, Berr C, Touboul PJ, Feve JM, Favier A, Ducimetiere P. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: the EVA Study: Etude sur le Vieillisement Arteriel. Am J Clin Nutr. 1997;65:121-127.
32. Simon E, Gariepy J, Cogny A, Moatti N, Simon A, Paul JL. Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease. Atherosclerosis. 2001;159:193-200.
33. Vasilaki AT, Leivaditi D, Talwar D, Kinsella J, Duncan A, O'Reilly DS, McMillan DC. Assessment of vitamin E status in patients with systemic inflammatory response syndrome: plasma, plasma corrected for lipids or red blood cell measurements? Clin Chim Acta. 2009;409:41-45.
34. Simon E, Paul JL, Atger V, Simon A, Moatti N. Study of vitamin E net mass transfer between a-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men. Free Radic Biol Med. 2000;28:815-823.
35. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol. 1999;19:266-275.
36. Nishida Y, Iwakoshi M, Nakagawa S, Mino M. Effect of body lipid mass on red blood cell-and plasma-tocopherol levels. J Nutr Sci Vitaminol (Tokyo). 1982;28:237-246.
37. Kitagawa M, Nakagawa S, Mino M. Influence of plasma lipids and adiposity on red blood cell tocopherol level. Eur J Pediatr. 1983;140: 238-243.
38. Schneider M, Verges B, Klein A, Miller ER, Deckert V, Desrumaux C, Masson D, Gambert P, Brun JM, Fruchart-Najib J, Blache D, Witztum JL, Lagrost L. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes. 2004;53:2633-2639.
39. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989;264: 21340-21345.
40. Uzel N, Sivas A, Uysal M, Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res. 1987;19:89-90.